KR20180024421A - Hangover drink comprising desalinized magma seawater and wood extracts and process for the production thereof - Google Patents
Hangover drink comprising desalinized magma seawater and wood extracts and process for the production thereof Download PDFInfo
- Publication number
- KR20180024421A KR20180024421A KR1020160110591A KR20160110591A KR20180024421A KR 20180024421 A KR20180024421 A KR 20180024421A KR 1020160110591 A KR1020160110591 A KR 1020160110591A KR 20160110591 A KR20160110591 A KR 20160110591A KR 20180024421 A KR20180024421 A KR 20180024421A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- composition
- oak
- hangover
- water
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 92
- 206010019133 Hangover Diseases 0.000 title claims abstract description 69
- 239000013535 sea water Substances 0.000 title claims abstract description 48
- 239000002023 wood Substances 0.000 title claims description 33
- 238000000034 method Methods 0.000 title claims description 23
- 238000004519 manufacturing process Methods 0.000 title description 16
- 230000008569 process Effects 0.000 title description 8
- 239000000203 mixture Substances 0.000 claims abstract description 72
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 43
- 244000010000 Hovenia dulcis Species 0.000 claims abstract description 19
- 235000008584 Hovenia dulcis Nutrition 0.000 claims abstract description 19
- 230000002265 prevention Effects 0.000 claims abstract description 11
- 241000219492 Quercus Species 0.000 claims description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 43
- 239000004480 active ingredient Substances 0.000 claims description 14
- 230000036541 health Effects 0.000 claims description 10
- 230000006872 improvement Effects 0.000 claims description 9
- 239000003643 water by type Substances 0.000 claims description 6
- 239000012298 atmosphere Substances 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 235000013376 functional food Nutrition 0.000 claims description 4
- 241001480055 Quercus mongolica Species 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 238000000909 electrodialysis Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 239000003456 ion exchange resin Substances 0.000 claims description 2
- 229920003303 ion-exchange polymer Polymers 0.000 claims description 2
- 238000001223 reverse osmosis Methods 0.000 claims description 2
- 241001480064 Quercus variabilis Species 0.000 claims 4
- 241000234280 Liliaceae Species 0.000 claims 1
- 241000234435 Lilium Species 0.000 claims 1
- 229920002774 Maltodextrin Polymers 0.000 claims 1
- 239000005913 Maltodextrin Substances 0.000 claims 1
- 240000000982 Malva neglecta Species 0.000 claims 1
- 235000000060 Malva neglecta Nutrition 0.000 claims 1
- 241000589516 Pseudomonas Species 0.000 claims 1
- 229940035034 maltodextrin Drugs 0.000 claims 1
- 239000011259 mixed solution Substances 0.000 claims 1
- 208000024891 symptom Diseases 0.000 abstract description 7
- 241000282414 Homo sapiens Species 0.000 abstract description 5
- 239000008280 blood Substances 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 abstract description 5
- 235000019441 ethanol Nutrition 0.000 description 38
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 22
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 21
- 230000000694 effects Effects 0.000 description 20
- XPFVYQJUAUNWIW-UHFFFAOYSA-N furfuryl alcohol Chemical compound OCC1=CC=CO1 XPFVYQJUAUNWIW-UHFFFAOYSA-N 0.000 description 18
- 108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 description 16
- 235000013305 food Nutrition 0.000 description 15
- 238000002360 preparation method Methods 0.000 description 15
- 235000013361 beverage Nutrition 0.000 description 14
- 230000035622 drinking Effects 0.000 description 11
- XLSMFKSTNGKWQX-UHFFFAOYSA-N hydroxyacetone Chemical compound CC(=O)CO XLSMFKSTNGKWQX-UHFFFAOYSA-N 0.000 description 10
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 9
- WOPKYMRPOKFYNI-UHFFFAOYSA-N 2-hydroxycyclopent-2-en-1-one Chemical compound OC1=CCCC1=O WOPKYMRPOKFYNI-UHFFFAOYSA-N 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 8
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 8
- 230000008030 elimination Effects 0.000 description 7
- 238000003379 elimination reaction Methods 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 239000003673 groundwater Substances 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- -1 respectively Chemical compound 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 235000019253 formic acid Nutrition 0.000 description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 description 6
- 239000011707 mineral Substances 0.000 description 6
- 235000010755 mineral Nutrition 0.000 description 6
- 239000000546 pharmaceutical excipient Substances 0.000 description 6
- 230000029058 respiratory gaseous exchange Effects 0.000 description 6
- 239000008399 tap water Substances 0.000 description 6
- 235000020679 tap water Nutrition 0.000 description 6
- XKEHLMZHBXCJGZ-UHFFFAOYSA-N 1,4,7,10,13,16,19-heptaoxacyclohenicosane Chemical compound C1COCCOCCOCCOCCOCCOCCO1 XKEHLMZHBXCJGZ-UHFFFAOYSA-N 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- SYIUWAVTBADRJG-UHFFFAOYSA-N 2H-pyran-2,6(3H)-dione Chemical compound O=C1CC=CC(=O)O1 SYIUWAVTBADRJG-UHFFFAOYSA-N 0.000 description 4
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 4
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 4
- INAXVXBDKKUCGI-UHFFFAOYSA-N 4-hydroxy-2,5-dimethylfuran-3-one Chemical compound CC1OC(C)=C(O)C1=O INAXVXBDKKUCGI-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- CVQUWLDCFXOXEN-UHFFFAOYSA-N Pyran-4-one Chemical compound O=C1C=COC=C1 CVQUWLDCFXOXEN-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 235000013334 alcoholic beverage Nutrition 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 230000001882 diuretic effect Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 239000013505 freshwater Substances 0.000 description 4
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 4
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 235000019359 magnesium stearate Nutrition 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229960003975 potassium Drugs 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 239000011435 rock Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 3
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 229910052785 arsenic Inorganic materials 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 239000012620 biological material Substances 0.000 description 3
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 238000011033 desalting Methods 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 239000011572 manganese Substances 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- TZIHFWKZFHZASV-UHFFFAOYSA-N methyl formate Chemical compound COC=O TZIHFWKZFHZASV-UHFFFAOYSA-N 0.000 description 3
- 108010033145 microsomal ethanol-oxidizing system Proteins 0.000 description 3
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 3
- 239000000123 paper Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 235000012222 talc Nutrition 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 244000163122 Curcuma domestica Species 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 2
- 240000008397 Ganoderma lucidum Species 0.000 description 2
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 150000005693 branched-chain amino acids Chemical class 0.000 description 2
- 229930188620 butyrolactone Natural products 0.000 description 2
- 229910052793 cadmium Inorganic materials 0.000 description 2
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 229960005233 cineole Drugs 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000004880 explosion Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229960001867 guaiacol Drugs 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 238000009616 inductively coupled plasma Methods 0.000 description 2
- 229940041476 lactose 100 mg Drugs 0.000 description 2
- 229940043353 maltol Drugs 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000000779 smoke Substances 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- YOMSJEATGXXYPX-UHFFFAOYSA-N 2-methoxy-4-vinylphenol Chemical compound COC1=CC(C=C)=CC=C1O YOMSJEATGXXYPX-UHFFFAOYSA-N 0.000 description 1
- NOEGNKMFWQHSLB-UHFFFAOYSA-N 5-hydroxymethylfurfural Chemical compound OCC1=CC=C(C=O)O1 NOEGNKMFWQHSLB-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000759832 Cornus walteri Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 235000001602 Digitaria X umfolozi Nutrition 0.000 description 1
- 235000017898 Digitaria ciliaris Nutrition 0.000 description 1
- 235000005476 Digitaria cruciata Nutrition 0.000 description 1
- 235000006830 Digitaria didactyla Nutrition 0.000 description 1
- 235000005804 Digitaria eriantha ssp. eriantha Nutrition 0.000 description 1
- 235000010823 Digitaria sanguinalis Nutrition 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 244000025670 Eleusine indica Species 0.000 description 1
- 235000014716 Eleusine indica Nutrition 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- DKKCQDROTDCQOR-UHFFFAOYSA-L Ferrous lactate Chemical compound [Fe+2].CC(O)C([O-])=O.CC(O)C([O-])=O DKKCQDROTDCQOR-UHFFFAOYSA-L 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 241001175904 Labeo bata Species 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 229930184510 Mallotus Natural products 0.000 description 1
- 241001060384 Mallotus <angiosperm> Species 0.000 description 1
- 241001149162 Mallotus japonicus Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 244000302512 Momordica charantia Species 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 235000004348 Perilla frutescens Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000758742 Saururaceae Species 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000245665 Taraxacum Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 241000691199 Taraxacum platycarpum Species 0.000 description 1
- 241001116498 Taxus baccata Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 241001106462 Ulmus Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- QOTQFLOTGBBMEX-UHFFFAOYSA-N alpha-angelica lactone Chemical compound CC1=CCC(=O)O1 QOTQFLOTGBBMEX-UHFFFAOYSA-N 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229940037769 calcium carbonate 100 mg Drugs 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 230000006999 cognitive decline Effects 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000004149 ethanol metabolism Effects 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000004225 ferrous lactate Substances 0.000 description 1
- 235000013925 ferrous lactate Nutrition 0.000 description 1
- 229940037907 ferrous lactate Drugs 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000011094 fiberboard Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229940014144 folate Drugs 0.000 description 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 230000010224 hepatic metabolism Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 210000001320 hippocampus Anatomy 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- RJGBSYZFOCAGQY-UHFFFAOYSA-N hydroxymethylfurfural Natural products COC1=CC=C(C=O)O1 RJGBSYZFOCAGQY-UHFFFAOYSA-N 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 238000000185 intracerebroventricular administration Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000002608 ionic liquid Substances 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- PVBQYTCFVWZSJK-UHFFFAOYSA-N meldonium Chemical compound C[N+](C)(C)NCCC([O-])=O PVBQYTCFVWZSJK-UHFFFAOYSA-N 0.000 description 1
- 229960002937 meldonium Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N methylene hexane Natural products CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 1
- WPHGSKGZRAQSGP-UHFFFAOYSA-N methylenecyclohexane Natural products C1CCCC2CC21 WPHGSKGZRAQSGP-UHFFFAOYSA-N 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 210000000651 myofibroblast Anatomy 0.000 description 1
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000004203 pancreatic function Effects 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- SOQGBGSEJYZNPS-UHFFFAOYSA-N permethyloctasilsesquioxane Chemical compound O1[Si](O[Si](C)(O2)O[Si](C)(O3)O4)(C)O[Si]4(C)O[Si]4(C)O[Si]1(C)O[Si]2(C)O[Si]3(C)O4 SOQGBGSEJYZNPS-UHFFFAOYSA-N 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 235000019997 soju Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 239000008227 sterile water for injection Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- CXEMWUYNUIKMNF-UHFFFAOYSA-N tert-butyl 4-chlorosulfonylpiperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCN(S(Cl)(=O)=O)CC1 CXEMWUYNUIKMNF-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940033203 vitamin b6 0.5 mg Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/334—Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/154—Water
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/34—Membrane process
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 헛개나무 추출물, 참나무 추출물 및 탈염 용암해수를 포함하는 숙취 예방 또는 개선용 조성물에 관한 것이다.The present invention relates to a composition for prevention or improvement of hangover comprising hinoki extract, oak extract and desalted lava sea water.
음주문화의 특성으로 나타나는 과음과 빈번한 음주로 인하여 숙취를 제거할 수 있는 약물에 대한 관심도가 매우 높다. 다른 식품과 달리 조직 내에 저장되지 못하는 알코올은 인체가 섭취한 알코올은 위장 점막의 알코올 탈수소효소(ADH: alcohol dehydrogenase) 및 마이크로좀 에탄올 산화계(MEOS : microsomal ethanol oxidizing system)에 의해 약 30%가 대사된다. 간에서의 에탄올 대사는 주로 NAD-linked enzymes, 즉 알코올 탈수소효소(ADH: alcohol dehydrogenase)와 아세트알데히드 탈수소효소(ALDH: Acetaldehyde dehydrogenase)에 의해 이루어진다. 이들 효소는 각각 아세트알데히드와 아세테이트를 생성하며 아세테이트는 acetyl-CoA로 전환되어 TCA 회로를 거쳐 에너지를 발생하거나 또는 콜레스테롤과 지방산 합성하는데 이용된다. 위장과 간의 ADH와 MEOS는 모두 알코올을 제 1단계 대사하여 아세트알데히드로 산화시키므로, 알코올이 이들 효소에 의해 대사됨에 따라 생성된 아세트알데히드 양이 증가하게 된다.Drugs that can remove hangovers due to frequent drinking and frequent alcoholic beverages are highly interested. Unlike other foods, alcohols that can not be stored in tissues are metabolized in the gastrointestinal mucosa by alcohol dehydrogenase (ADH) and microsomal ethanol oxidizing system (MEOS). . The ethanol metabolism in the liver is mainly by NAD-linked enzymes (alcohol dehydrogenase (ADH) and acetaldehyde dehydrogenase (ALDH). These enzymes produce acetaldehyde and acetate, respectively, and acetate is converted to acetyl-CoA to generate energy via TCA circuitry or to synthesize cholesterol and fatty acids. Both ADH and MEOS in the stomach and liver oxidize alcohol to acetaldehyde in the first step, so that the amount of acetaldehyde produced increases as the alcohol is metabolized by these enzymes.
아세트알데히드는 생체 내에서 단백질을 비롯한 중요 활성물질과 결합하여 맥박의 증가, 발한, 오심, 구토 등의 증상을 유발한다. 알코올 대사의 제 2단계는 아세트알데히드 탈수소효소(ALDH : acetaldehyde dehydrogenase)가 아세트알데히드를 아세테이트로 산화시켜 아세트알데히드의 축적과 그에 따른 부작용을 막을 수 있으나 한국인의 15% 이상이 ALDH의 불활성형을 가지고 있어 음주 시 아세트알데히드의 축적으로 인한 상기 증상들이 나타날 수 있다.Acetaldehyde binds to important active substances, including proteins, in vivo, causing symptoms such as increased pulse, sweating, nausea, and vomiting. The second step in the metabolism of alcohol is the acetaldehyde dehydrogenase (ALDH) which oxidizes acetaldehyde to acetate to prevent the accumulation of acetaldehyde and its side effects, but over 15% of Koreans have an inactive form of ALDH The above symptoms due to the accumulation of acetaldehyde may occur during drinking.
숙취는 술을 마신 후에 나타나는 두통, 설사, 식욕부진, 오심, 구토, 오한, 식은땀을 뜻하며 객관적인 증상으로는 인식, 운동 능력 저하, 혈액학적 변화 및 호르몬 변화로 정의할 수 있다. Hangover refers to headache, diarrhea, anorexia, nausea, vomiting, chills, and cold sweating that occur after drinking alcohol. Objective symptoms include cognitive decline, decreased exercise capacity, hematologic changes, and hormonal changes.
알코올은 섭취량에 따라 간 대사에 여러 가지 영향을 미치는 것으로 알려져 있는데, 알코올 그 자체보다도 산화과정에서 생성된 아세트알데히드와 NADH가 간세포에 손상을 가져오게 된다. 체내에 흡수된 알코올이 ADH(alchol dehydrogenase)에 의해 NAD이온과 반응하여 NADPH와 아세트알데히드로 전환되고 이어서 다시 NAD 이온과 함께 반응하여 ALDH(aldehyde dehydrogenase)에 의해 아세트알데히드가 NADPH와 아세테이트로 전환된다. 숙취는 아세트알데히드로 인해 생기는 것이고 ADH와 ALDH 모두가 있어야 숙취 해소과정이 이뤄질 수 있다. 숙취를 감소시킬 수 있는 약물을 찾는 연구들이 이미 많이 이루어졌으며, 최근 들어 에탄올의 독성을 경감시키거나 독성의 발현을 저해할 수 있는 물질에 대한 연구와 실험이 진행된 결과 천연식품이나 한약재료로부터 추출한 성분이나 인공제재를 함유한 다양한 건강보조식품이 개발되고 있다. 그러나, 아직까지 현저한 숙취 해소 효과를 나타내는 것은 많지 않은 실정이다. Alcohol is known to have various effects on liver metabolism depending on its intake. Acetaldehyde and NADH produced in the oxidation process are more damaging to hepatocytes than alcohol itself. Alcohol absorbed in the body reacts with NAD ions by ADH (alchol dehydrogenase), converts to NADPH and acetaldehyde, and then reacts with NAD ion again to convert acetaldehyde to NADPH and acetate by aldehyde dehydrogenase (ALDH). Hangover is caused by acetaldehyde, and both ADH and ALDH can be achieved by hangover resolution. There have been many studies to find drugs that can reduce hangover. Recently, researches and experiments on substances that can reduce the toxicity of ethanol or inhibit the expression of toxins have been conducted. As a result, Or a variety of health supplements containing artificial agents are being developed. However, there have not been many cases in which significant hangover resolution effect has been shown yet.
한편, 천연의 생물자원인 목재는 다량의 섬유질을 함유한 다공성 생물재료로서 공기중의 이산화탄소와 물에 의해 태양의 촉매작용으로 만들어지는 약리성분을 가진 포도당이나 자일란, 글로코만난, 갈락탄 등의 다당류와 단당류 등의 생물재료의 보고이다. 고분자재료인 이들 성분은 일전한 열과 압력조건에 의해 저분자로 분해되며, 그 약리성분은 사람이나 동물, 심지어 식물의 성장에도 유효한 약리성분이 많은 것으로 잘 알려져 있다. On the other hand, wood, which is a natural biological resource, is a porous biological material containing a large amount of fiber. It is a kind of porous biomaterial such as glucose, which has a pharmacological component catalyzed by the sun by carbon dioxide and water in water, or glutaraldehyde It is a report of biological materials such as polysaccharides and monosaccharides. These components, which are polymeric materials, are decomposed to low molecular weight by the prevailing heat and pressure conditions, and their pharmacological components are known to have many pharmacological components which are effective for the growth of human beings, animals, and even plants.
용암해수는 바닷물이 투수성이 좋은 화산 암반층에 의해 자연 여과되면서 육지 지하로 흘러든 지하 해수로서, 제주 동부지역에 주로 매장되어 있으며, 연안으로부터 최대 8km까지 흘러 화산 암반층을 통과해 들어오는 것으로 알려져 있다. 상기 용암해수는 담수 지하수와의 밀도 차이에 의해 서로 섞이지 않으며, 담수층 아래에 존재한다.Lava seawater is an underground seawater flowing into the ground under natural filtration of seawater by a permeable volcanic rock layer. It is mainly buried in the eastern part of Jeju. It flows up to 8km from the coast and is known to pass through the volcanic rock layer. The lava seawater is not mixed with each other due to the difference in density with freshwater groundwater, and exists below the freshwater layer.
구체적으로 제주도 동부지역은 행정구역상 제주도 구좌읍, 성산읍 및 표선면을 의미하며, "염지하수"는 일정량 이상 염분이 함유된 지하수를 의미하는데, 구체적으로는 고기원 등의 논문(고기원 등, 제주도 동부지역의 수문지질에 관한 연구(Ⅱ), 2003, 경원대학교)에서 사용한 염분 농도에 의거 제주도 지하수를 분류한 기준에 따라 저염지하수(전기전도도가 1,700㎲/cm ~17,350㎲/cm)와 염수지하수(전기전도도가 17,350㎲/cm 이상)를 모두를 포함하는 의미로서 이해될 수 있지만, 바람직하게는 전기전도도가 17,350 ㎲/cm 이상 또는 염의 농도가 30‰(permilliage) 이상(통상 해수의 염분 농도가 32 내지 35‰임)인 염수지하수를 의미하는 것으로 이해될 수 있다. Specifically, the eastern part of Jeju Island refers to Gujwa-eup, Seosan-eup, and Jeonseon-myeon in Cheju Island in the administrative district, and "saltwater groundwater" refers to groundwater containing salinity of a certain amount or more. Specifically, (Electrical conductivity of 1,700 μs / cm to 17,350 μs / cm) and brine groundwater (Kwangwon Univ.) In accordance with the criteria for classification of groundwater in Jeju Island, Preferably not less than 17,350 占 / / cm or a salt concentration of 30 ‰ (permilliage) or more (usually, the salt concentration of seawater is 32 ≪ / RTI > to < RTI ID = 0.0 > 35 < / RTI >
용암해수는 현무암층을 통과하는 과정에서 자연 정화되기 때문에 매우 청정하고, 깊은 바다에서 취수되는 해양심층수와는 달리, 육지에서 취수가 가능하기 때문에 비용 효율이 우수하며, 제주도에서 생산되는 용암해수는 매우 희귀한 소재로서 제주도만의 브랜드제품을 만드는데 있어서 매우 유용할 것으로 판단되므로, 수많은 관광객을 대상으로 한 세계화 제품으로 도약할 수 있을 것으로 기대되는 주요 소재이다.Since lava seawater is naturally purified during the passage through the basaltic layer, it is very clean and unlike deep sea water which is taken from deep sea, it is cost effective because it can be taken from the land. Lava seawater produced in Jeju Island is very rare Since it is considered to be very useful for making Jeju Island brand products as a material, it is expected to become a global product for many tourists.
또한, 상기 용암해수는 일반 염지하수나 해수에서 볼 수 없는 다양한 미네랄을 다량으로 함유하고 있으며, 특히, 용암해수 내 미량으로 포함되어 있는 바나듐은 인슐린 분비를 안정시키는 작용이 있다고 알려져 있고, 게르마늄은 혈액순환 촉진, 면역력 증강, 항암 작용 등에 효과가 있고, 셀레늄은 지방의 산화작용 억제, 항산화 활성, 항암, 불임, 노화 억제, 및 콜레스테롤 수치의 개선 효과가 있다고 보고된 바 있으나, 숙취해소제에 관한 것은 전무한 실정이다. In addition, the lava water contains a large amount of various minerals not found in general salt ground water or seawater. In particular, it is known that vanadium contained in trace amounts in lava seawater has an action of stabilizing insulin secretion, It has been reported that selenium inhibits the oxidation of fat, antioxidant activity, anticancer, infertility, suppression of aging, and improvement of cholesterol level. However, regarding the hangover remedy There is no such thing.
본 발명자들은 숙취를 해소하기 위해 연구 노력한 결과, 헛개나무 추출물, 참나무 추출물 및 탈염 용암해수를 유효성분으로 함유하는 조성물이 음주 후 혈중 내 알코올 함량을 감소시키고, 알코올 탈수소효소 및 아세트알데히드 탈수소효소 활성을 증대시킬 수 있음을 확인하고, 본 발명을 완성하였다.As a result of efforts to solve the hangover, the inventors of the present invention have found that a composition containing an extract of Hovenia dulcis, an extract of oak, and a deionized sea water as an active ingredient decreases the alcohol content in the blood after drinking and the alcohol dehydrogenase and acetaldehyde dehydrogenase activity And the present invention has been completed.
본 발명의 목적은 헛개나무 추출물, 참나무 추출물 및 탈염 용암해수를 유효성분으로 포함하는 숙취해소용 조성물을 제공하는 것이다.It is an object of the present invention to provide a composition for hunting hunting which comprises Hovenia dulcis extract, oak extract and desalted lava sea water as an active ingredient.
상기 목적을 달성하기 위해, 본 발명은 헛개나무 추출물, 참나무 추출물 및 탈염 용암해수를 유효성분으로 포함하는 숙취 예방 또는 개선용 조성물을 제공한다.In order to accomplish the above object, the present invention provides a composition for preventing or improving hangover comprising Hovenia dulcis extract, oak extract and desalted lava sea water as an active ingredient.
또한 본 발명은 헛개나무 추출물, 참나무 추출물 및 탈염 용암해수를 유효성분으로 함유하는 숙취 예방 또는 개선용 건강기능식품을 제공한다.The present invention also provides a health functional food for prevention or improvement of hangover, which comprises Hovenia dulcis extract, oak extract, and desalted lava sea water as an active ingredient.
또한 본 발명은 헛개나무 추출물, 참나무 추출물 및 탈염 용암해수를 유효성분으로 함유하는 숙취해소용 음료를 제공한다.In addition, the present invention provides a hangover herb drink containing as an active ingredient a hinoki extract, an oak extract, and desalted lava sea water.
본 발명의 헛개나무 추출물, 참나무 추출물 및 탈염 용암해수는 인체 혈중 알코올 농도를 감소시키고, 숙취 증상을 완화시킴으로써 숙취 예방 또는 개선에 유용하게 사용될 수 있다.The Hovenia dulcis extract, oak extract and desalted lava sea water of the present invention can be usefully used for prevention or improvement of hangover by reducing blood alcohol concentration in the human body and alleviating hangover symptoms.
도 1은 참나무 추출물의 제조과정을 개략적으로 나타낸 도이다.
도 2는 헛개나무 추출물의 성분 분석 결과를 GC/MS 스펙트럼을 통해 나타낸 도이다.
도 3은 갈화 추출물의 성분 분석 결과를 GC/MS 스펙트럼을 통해 나타낸 도이다.
도 4는 울금 추출물의 성분 분석 결과를 GC/MS 스펙트럼을 통해 나타낸 도이다.
도 5는 헛개나무 추출물의 성분 분석 결과를 GC/MS 스펙트럼을 통해 나타낸 도이다.
도 6은 본 발명의 조성물의 아세트알데히드 분해 효소 활성 측정 결과를 나타낸 도이다.
도 7은 알코올 섭취 전 본 발명의 조성물을 섭취한 임상대상자들의 호흡 중 알코올 농도를 측정한 결과를 나타낸 도이다.
도 8은 알코올 섭취 전 본 발명의 조성물을 섭취한 임상대상자들의 호흡 중 알코올 농도를 흡연 유무로 구분하여 측정한 결과를 나타낸 도이다.
도 9는 알코올 섭취 전 본 발명의 조성물을 섭취한 임상대상자들의 호흡 중 알코올 농도를 성별로 구분하여 측정한 결과를 나타낸 도이다.FIG. 1 schematically shows a process for producing an oak extract.
FIG. 2 is a graph showing the compositional analysis results of the Hovenia dulcis extract through a GC / MS spectrum.
Fig. 3 is a graph showing the result of analyzing the components of the crabgrass extract through a GC / MS spectrum.
FIG. 4 is a graph showing the result of analyzing the composition of the uroguide extract through a GC / MS spectrum. FIG.
FIG. 5 is a graph showing the compositional analysis results of the Hovenia dulcis extract through a GC / MS spectrum.
6 is a graph showing the results of measurement of acetaldehyde degrading enzyme activity of the composition of the present invention.
FIG. 7 is a graph showing the results of measurement of respiration alcohol concentration in clinical subjects who ingest the composition of the present invention before alcohol consumption. FIG.
FIG. 8 is a graph showing the results of measurement of alcohol concentration during breathing of clinical subjects who ingest the composition of the present invention before alcohol consumption, by discriminating whether or not to smoke.
FIG. 9 is a graph showing the results of measurement of alcohol concentration during breathing of the clinical subjects who ingested the composition of the present invention before alcohol consumption, by sex.
본 발명은 헛개나무 추출물, 참나무 추출물 및 탈염 용암해수를 유효성분으로 포함하는 숙취 예방 또는 개선용 조성물을 제공한다. The present invention provides a composition for prevention or improvement of hangover comprising Hovenia dulcis extract, oak extract and desalted lava sea water as an active ingredient.
상기 조성물은 약학적 조성물 또는 식품 조성물을 포함한다.The composition comprises a pharmaceutical composition or a food composition.
이하, 본 발명에 대하여 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명의 유효성분인 헛개나무 추출물 및 참나무 추출물은 당업계에 공지된 추출 및 분리하는 방법을 사용하여 각각 목재로부터 추출 및 분리하여 수득한 것을 사용할 수 있으며, 본 발명에서 정의된 '추출물'은 적절한 용매를 이용하여 추출된 조추출물, 극성용매 가용 추출물 또는 비극성용매 가용 추출물을 모두 포함한다.The extracts of hinoki and oak, which are active ingredients of the present invention, can be obtained by extracting and isolating from wood each using an extraction and separation method known in the art, and the 'extract' as defined in the present invention is suitable Crude extracts extracted using a solvent, polar solvent-soluble extracts, or non-polar solvent-soluble extracts.
상기 헛개나무(Oriental raisin tree; Hovenia dulcis)는 갈매나무과의 낙엽교목으로서 지구자나무라고도 하며, 상기 참나무(Oak)는 참나무과에 속하는 낙엽활엽수를 말하는 것으로, 신갈나무, 떡갈나무, 굴참나무, 갈참나무, 상수리나무, 또는 졸참나무를 포함할 수 있으며, 바람직하게는 신갈나무일 수 있다.The Oriental raisin tree ( Hovenia dulcis ) is a deciduous tree belonging to the family Seagull and is also referred to as a seed tree. The oak refers to a deciduous broad-leaved tree belonging to the oak tree and includes quercus mongolica, oak tree, oak oak, oak tree, oak tree, And may be preferably a Quercus mongolica.
상기 헛개나무 추출물 및 참나무 추출물은 잎, 꽃, 뿌리, 줄기, 가지, 껍질 및 과실 등의 다양한 기관 또는 부분으로부터 추출하여 얻은 것을 의미할 수 있으나, 바람직하게는 목질부, 보다 바람직하게는 껍질(즉, 수피)로부터 얻은 추출물일 수 있다. The hinoki extract and the oak extract may be obtained by extracting from various organs or parts such as leaves, flowers, roots, stems, branches, husks and fruits, but preferably they are obtained from woody parts, Bark). ≪ / RTI >
추출을 위한 적절한 용매로는 물 또는 약학적으로 허용되는 유기용매로서 어느 것을 사용해도 무방하다. 예를 들어, 상기 용매로는 물, 메탄올(methanol), 에탄올(ethanol), 프로판올(propanol), 이소프로판올(isopropanol) 및 부탄올(butanol) 등의 탄소수 1 내지 4의 알코올, 아세톤(acetone), 에테르(ether), 벤젠(benzene), 클로로포름(chloroform), 에틸아세테이트(ethyl acetate), 메틸렌클로라이드(methylene chloride), 헥산(hexane), 시클로헥산(cyclohexane) 등의 각종 용매를 단독으로 또는 2종 이상 혼합하여 사용할 수 있으며, 바람직하게는 물이다.As a suitable solvent for extraction, any of water or a pharmaceutically acceptable organic solvent may be used. Examples of the solvent include alcohols having 1 to 4 carbon atoms such as water, methanol, ethanol, propanol, isopropanol, and butanol, acetone, ether various solvents such as ether, benzene, chloroform, ethyl acetate, methylene chloride, hexane and cyclohexane may be used alone or as a mixture of two or more thereof. And preferably water.
추출 방법으로는 열수추출법, 냉침추출법, 환류냉각추출법, 용매추출법, 수증기증류법, 초음파추출법, 용출법, 압착법 등의 방법이 사용될 수 있으며, 바람직하게는 열수추출법을 이용한다. Examples of the extraction method include hot water extraction, cold extraction, reflux cooling, solvent extraction, steam distillation, ultrasonic extraction, elution, and compression.
또한 목적하는 추출물은 추가로 통상의 분획 공정을 수행할 수도 있으며, 통상의 정제 방법을 이용하여 정제될 수도 있다. 예를 들어, 본 발명의 조성물의 유효성분인 헛개나무 추출물 및 참나무 추출물은 1차 추출물을, 감압 증류 및 동결 건조 또는 분무 건조 등과 같은 추가적인 과정에 의해 분말 상태로 제조할 수 있다. 또한 상기 1차 추출물을 실리카겔 컬럼 크로마토그래피(silica gel column chromatography), 박층크로마토그래피(thin layer chromatography), 고성능 액체 크로마토그래피(high performance liquid chromatography) 등과 같은 다양한 크로마토그래피를 이용하여 추가로 정제된 분획으로도 얻을 수 있다.The desired extract may further be subjected to a conventional fractionation process or may be purified using a conventional purification method. For example, the extract of Hovenia dulcis and the extract of oak, which are effective components of the composition of the present invention, can be prepared into a powdery state by an additional process such as vacuum distillation, freeze-drying, or spray drying. In addition, the primary extract can be further purified into a further purified fraction using various chromatographies such as silica gel column chromatography, thin layer chromatography, high performance liquid chromatography and the like Can be obtained.
따라서 본 발명에서 사용되는 추출물은 추출, 분획 또는 정제의 각 단계에서 얻어지는 모든 추출액, 분획 및 정제물, 그들의 희석액, 농축액 또는 건조물을 모두 포함하는 개념이다.Therefore, the extract used in the present invention is a concept including all the extracts, fractions and tablets obtained in each step of extraction, fractionation or purification, their diluted solution, concentrate or dried product.
본 발명의 일실시예에서는 헛개나무 추출물 및 참나무 추출물을 수득하기 위하여 목재를 물 또는 탄소수 1 내지 4의 알코올, 바람직하게는 물로 바람직하게는 50~200℃에서 0.1~3시간 동안 열수추출한 후 여과 및 감압 농축과정을 거쳐 참나무 추출물을 수득하였다. In one embodiment of the present invention, the wood is hydrolyzed with water or an alcohol having 1 to 4 carbon atoms, preferably water, preferably at 50 to 200 DEG C for 0.1 to 3 hours to obtain a hinoki extract and an oak extract, The oak extract was obtained through vacuum concentration.
구체적으로는, 목재 칩을 물에 침지시킨 후 탈수시키는 공정; 상기 탈수된 목재 칩을 70~150℃에서 0.5~3시간 동안 가열하는 공정; 상기 가열된 목재 칩과 수증기를 120~300℃의 온도 및 10~40kgf/㎠의 압력에서 0.1~1시간 동안 반응시켜 연화하는 공정; 상기 연화된 목재 칩을 대기중에 방출하여 팽창시키는 공정; 상기 팽창된 목재 칩을 50~200℃에서 열수추출하는 공정; 및 상기 추출물을 분리, 정제 및 감압 농축하는 공정;을 통해 수득하였다.Specifically, a process of dipping a wooden chip in water and then dehydrating it; Heating the dehydrated wood chips at 70 to 150 DEG C for 0.5 to 3 hours; A step of softening the heated wood chips and water vapor by reacting them at a temperature of 120 to 300 ° C and a pressure of 10 to 40 kgf / cm 2 for 0.1 to 1 hour; Releasing and expanding the softened wood chips into the atmosphere; Subjecting the expanded wood chips to hot water extraction at 50 to 200 DEG C; And a step of separating, purifying and concentrating the extract under reduced pressure.
또한, 상기 참나무 추출물은 상기 탈수 공정 전에, 목재를 벌채하여 수피를 제거하는 박피 작업 후, 칩 제조기로 잘라 목재 칩을 제조하는 공정 및 물리적, 화학적, 생물학적 전처리 공정을 전처리 공정을 더 포함할 수 있다. 상기 전처리 공정은 폭쇄법(explosion), 알칼리 처리법, 이산화황 처리법, 과산화수소 처리법, 초임계 암모니아 처리법, 약산 추출 처리법, 암모니아 폭쇄법, 이온성 액체 처리법 등이 있으며, 바람직하게는 폭쇄법일 수 있다. In addition, the oak extract may further include a step of cutting wood with wood chips to remove bark after the dehydrating process, a step of cutting with a chip maker to produce a wood chip, and a pretreatment step of physical, chemical, and biological pretreatment . The pretreatment step may be explosion, alkali treatment, sulfur dioxide treatment, hydrogen peroxide treatment, supercritical ammonia treatment, weak acid extraction treatment, ammonia explosion, ionic liquid treatment, and the like.
폭쇄법은 마소나이트법(Masonite process), 건법(gun) 등으로 불리는 섬유판 제조법의 일종으로, 목재칩을 고온에서 고기압의 증기로 처리하고 대기 중에 급격히 방출시켜 칩을 해리하는 방법이다. 고압이 작용하여 목재를 작은 조각으로 분해시킬 수 있다. The blowing method is a method of producing a fiber board called "Masonite process" or "gun". It is a method of disassembling a chip by treating a wood chip with high-pressure steam at a high temperature and rapidly discharging it into the atmosphere. The high pressure acts to break down the wood into small pieces.
상기 헛개나무 추출물 및 참나무 추출물은 조성물 총 중량에 대하여 0.01~95중량%로 포함될 수 있으며, 바람직하게는 1~80중량%, 더욱 바람직하게는 1~20중량%로 포함될 수 있다. 그 함량이 0.01중량% 미만일 경우에는 복용의 효율성이 떨어질 수 있으며, 95중량%를 초과할 경우에는 제형화에 어려움이 있을 수 있다.The hinoki extract and the oak extract may be contained in an amount of 0.01 to 95% by weight, preferably 1 to 80% by weight, more preferably 1 to 20% by weight based on the total weight of the composition. If the content is less than 0.01% by weight, the efficiency of taking may be poor. If the content is more than 95% by weight, formulation may be difficult.
본 발명의 또다른 유효성분인 "탈염 용암해수"는 용암해수를 탈염시켜 얻어진 결과물로서 이 결과물은 일부 탈수된(수분이 일부 제거된) 농축된 액상의 성상이거나 완전히 탈수된 분말상의 성상일 수 있다. 이 탈염 용암해수는 그 상(phase)이 특별히 제한되지 아니하는 미네랄 성분들의 조성물로 이해될 수 있다. Another effective ingredient of the present invention, "desalted lava sea water" is a result obtained by desalting lava seawater. The resultant may be a partially dehydrated (with some water removed) concentrated liquid phase property or a fully dehydrated powder phase property . This desalted lava sea water can be understood as a composition of mineral components whose phase is not particularly limited.
상기 "용암해수"는 바닷물이 투수성이 좋은 화산 암반층에 의해 자연 여과되면서 육지 지하로 흘러든 지하 해수로서, 제주도, 바람직하게는 제주 동부지역(제주도 구좌읍, 성산읍 및 표선면)에 주로 매장되어 있으며, 연안으로부터 최대 8km까지 흘러 화산 암반층을 통과해 들어오는 것으로 알려져 있다. 상기 용암해수는 담수 지하수와의 밀도 차이에 의해 서로 섞이지 않으며, 담수층 아래에 존재한다.The above-mentioned "Lava Seawater" is an underground seawater flowing into the ground under natural filtration of seawater by a permeable volcanic rock layer. It is mainly buried in Jeju Island, preferably in the eastern part of Jeju Island (Jeju Island, Seosan-eup and Jeolseon-myeon) It flows up to 8km from the coast and is known to pass through the volcanic rock layer. The lava seawater is not mixed with each other due to the difference in density with freshwater groundwater, and exists below the freshwater layer.
용암해수를 탈염시켜 탈염 용암해수를 얻는 방법은 당업계에 알려진 임의의 기술을 적용하여 수행될 수 있으며, 그 기술로서 역삼투압법, 이온교환수지법 또는 전기투석법 등을 들 수 있다.A method of desalting lava sea water to obtain desalted lava sea water can be carried out by applying any technique known in the art, and examples thereof include reverse osmosis method, ion exchange resin method, and electrodialysis method.
본 발명의 조성물에 있어서, 탈염 용암해수는 용암해수를 탈염시켜 얻어진 결과물 자체이며, 탈수시킨 탈염 용암해수를 이용할 경우 탈수된 양만큼의 물이 첨가된 탈염 용암해수를 기준으로 한다. In the composition of the present invention, the desalted lava water is the result obtained by desalting lava seawater, and when dehydrated lava lava is used, it is based on desalted lava water to which dehydrated amount of water is added.
또한 본 발명의 조성물은 예덕나무( Mallotus japonicus) 추출물을 더 포함할 수 있다.In addition, compositions of the present invention mallotus (Mallotus japonicus ) extract.
상기 예덕나무는 쌍떡잎식물 이판화군 쥐손이풀 대극과의 낙엽 소교목으로서 주로 바닷가에서 자라며, 바람직하게는 제주도산일 수 있다.The yew tree is a deciduous arboreous tree with dicotyledonous deciduous forests and mainly grows on the beach, and can be preferably a mountain of Jeju Island.
상기 예덕나무 추출물은 잎, 꽃, 뿌리, 줄기, 가지, 껍질 및 과실 등의 다양한 기관 또는 부분으로부터 추출하여 얻은 것을 의미하고, 바람직하게는 줄기, 가지, 껍질 또는 뿌리, 보다 바람직하게는 껍질(즉, 수피)로부터 얻은 추출물일 수 있다.The Yedoaceae extract is obtained by extracting from various organs or parts such as leaves, flowers, roots, stems, branches, bark and fruit, and preferably refers to a stem, branch, shell or root, , Bark).
또한 본 발명의 조성물은 갈화, 어성초, 여주, 울금, 자소엽, 포공영 또는 빼빼목 추출물을 더 포함할 수 있다.In addition, the composition of the present invention may further comprise an extract of Galapthong, Ganoderma lucidum, Yeoju, Ulugum, Japanese, Punggol, or Scutellaria.
상기 갈화(Puerarialo bata)는 칡의 꽃을 건조시킨 것으로 갈증, 식욕부진, 복부팽만, 구토 등에 널리 사용되는 재료이다. Puerarialo bata is a dried flower of 칡, widely used for thirst, anorexia, abdominal distension, vomiting and so on.
상기 어성초(Houttuynia cordata Thunb)는 삼백초과(Saururaceae)에 속하는 다년생 초본식물로서 한방에서 지혈, 이뇨, 이습, 소종, 영심, 해독, 타박상, 출혈, 혈변, 심계 및 부종 치료에 효능이 있다고 알려져 있다.The Houttuynia cordata Thunb) is a perennial herbaceous plant belonging to Saururaceae . It is known to be effective in the treatment of hemostasis, diuretic, diuretic, humoral, swelling, spontaneous, detoxification, bruising, hemorrhage,
상기 여주(Momordica charantia)는 박목, 박과의 덩굴성 한해살이풀로서 식용, 관상용, 약용 등으로 널리 쓰이며, 특히 약용으로서 간 보호, 항종양 작용, 항산화 작용에 효능이 있다고 알려져 있다.The Momordica charantia ) is a vine-grown herbaceous herb that has been widely used for edible, ornamental, and medicinal purposes. It is known to be effective for liver protection, antitumor action, and antioxidant activity.
상기 울금(Curcuma longa L., turmeric)은 생강과에 속하는 다년생 숙근 초본 식물로 울금의 덩이뿌리를 그대로 또는 수피를 제거하고 쪄서 말린 것으로 한약재, 향신료 및 식용으로 사용되어져 왔으며, 항산화, 항암성, 항돌연변이성, 항염증 및 항균성에 효과가 있는 것으로 알려져 있다. Curcuma longa L. (turmeric) is a perennial herbaceous herbaceous plant belonging to the genus Ginger and has been used for herbal medicines, spices and edible products, It is known to be effective for mutagenic, anti-inflammatory and antimicrobial properties.
상기 자소엽은 차조기(Perilla frutescens)의 잎으로 발한, 지혈, 해열, 진통, 진정 및 피부질환에 사용되며, 식중독 예방 및 피로회복 등에도 효능이 있는 것으로 알려져 있다.The chair Leaflets are perilla (Perilla frutescens ) is used for sweating, hemostasis, fever, analgesia, sedation and skin diseases. It is also known to be effective for preventing food poisoning and restoring fatigue.
상기 포공영(Taraxacum platycarpum)은 간질환 및 여성 질환을 치료하기 위한 전통적인 약재로 사용되어 왔으며, 간, 췌장, 위장의 기능을 개선하고, 주로 이뇨제의 역할을 한다. Taraxacum platycarpum has been used as a traditional medicament for the treatment of liver diseases and female diseases and improves liver, pancreas and gastrointestinal function and plays a role of diuretic.
상기 빼빼목(Cornus walteri wagner)은 층층나무과에 속하며, 해독작용, 해열작용 및 이뇨작용에 효과적인 것으로 알려져 있다.The above-mentioned Cornus walteri wagner belongs to the order Tertiary, and is known to be effective for detoxification, antipyretic action and diuretic action.
본 발명자는 헛개나무 추출물, 참나무 추출물 및 탈염 용암해수를 포함하는 본 발명의 조성물이 인체 혈중 알코올 농도를 감소시키고, 숙취 증상을 완화시킴을 확인하였다. The present inventors have confirmed that the composition of the present invention including hinoki extract, oak extract, and desalted lava sea water reduces the blood alcohol concentration in the human body and alleviates the hangover symptoms.
본 발명의 조성물은 상기 헛개나무 추출물, 참나무 추출물 및 탈염 용암해수와 함께 숙취 해소 효과를 갖는 공지의 유효성분을 1종 이상 더 함유할 수 있다. The composition of the present invention may further contain one or more known active ingredients having a hangover resolution effect together with the Hovenia dulcis extract, the oak extract, and the desalted lava sea water.
본 발명의 조성물은 조성물의 제조에 통상적으로 사용하는 적절한 담체, 부형제 및 희석제를 더 포함할 수 있다. 또한 통상의 방법에 따라 산제, 과립제, 정제, 캡슐제, 현탁액, 에멀젼, 시럽, 에어로졸 등의 경구형 제형, 외용제, 좌제 및 멸균 주사용액의 형태로 제형화하여 사용될 수 있다. 당해 기술 분야에 알려진 적합한 제제는 문헌(Remington's Pharmaceutical Science, 최근, Mack Publishing Company, Easton PA)에 개시되어 있는 것을 사용하는 것이 바람직하다. 포함될 수 있는 담체, 부형제 및 희석제로는 락토오스, 덱스트로오스, 수크로오스, 소르비톨, 만니톨, 자일리톨, 에리스리톨, 말티톨, 전분, 아카시아 고무, 알지네이트, 젤라틴, 칼슘 포스페이트, 칼슘 실리케이트, 셀룰로오스, 메틸 셀룰로오스, 미정질 셀룰로오스, 폴리비닐 피롤리돈, 물, 메틸히드록시 벤조에이트, 프로필히드록시 벤조에이트, 탈크, 마그네슘 스테아레이트 및 광물유 등이 있다. 상기 조성물을 제제화할 경우에는 보통 사용하는 충진제, 증량제, 결합제, 습윤제, 붕해제, 계면활성제 등의 희석제 또는 부형제를 사용하여 조제된다. 경구투여를 위한 고형제제에는 정제, 환제, 산제, 과립제, 캡슐제 등이 포함되며, 이러한 고형제제는 상기 조성물에 적어도 하나 이상의 부형제 예를 들면, 전분, 칼슘카보네이트(calcium carbonate), 수크로오스, 락토오스, 젤라틴 등을 섞어 조제된다. 또한 단순한 부형제 이외에 마그네슘 스테아레이트, 탈크 같은 윤활제들도 사용된다. 경구를 위한 액상 제제로는 현탁제, 내용액제, 유제, 시럽제 등이 해당되는데 흔히 사용되는 단순 희석제인 물, 리퀴드 파라핀 이외에 여러 가지 부형제, 예를 들면 습윤제, 감미제, 방향제, 보존제 등이 포함될 수 있다. 비경구 투여를 위한 제제에는 멸균된 수용액, 비수성용제, 현탁제, 유제, 동결건조 제제, 좌제가 포함된다. 비수성용제, 현탁제로는 프로필렌글리콜(propylene glycol), 폴리에틸렌 글리콜, 올리브 오일과 같은 식물성 기름, 에틸올레이트와 같은 주사 가능한 에스테르 등이 사용될 수 있다. 좌제의 기제로는 위텝솔(witepsol), 마크로골, 트윈(tween) 61, 카카오지, 라우린지, 글리세로제라틴 등이 사용될 수 있다. The compositions of the present invention may further comprise suitable carriers, excipients and diluents conventionally used in the manufacture of the compositions. In addition, it can be formulated in the form of powders, granules, tablets, capsules, suspensions, emulsions, oral preparations such as syrups and aerosols, external preparations, suppositories and sterilized injection solutions according to a conventional method. Suitable formulations known in the art are preferably those as disclosed in Remington ' s Pharmaceutical Science, recently, Mack Publishing Company, Easton PA. Examples of carriers, excipients and diluents which may be included include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, acacia rubber, alginate, gelatin, calcium phosphate, calcium silicate, cellulose, methylcellulose, Cellulose, polyvinylpyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate, and mineral oil. When the composition is formulated, it is prepared using a diluent such as a filler, an extender, a binder, a wetting agent, a disintegrant, a surfactant, or an excipient usually used. Solid formulations for oral administration include tablets, pills, powders, granules, capsules and the like, which may contain at least one excipient such as starch, calcium carbonate, sucrose, lactose, Gelatin and the like. In addition to simple excipients, lubricants such as magnesium stearate and talc are also used. Examples of the liquid preparation for oral use include suspensions, solutions, emulsions, and syrups. In addition to water and liquid paraffin, simple diluents commonly used, various excipients such as wetting agents, sweeteners, fragrances, preservatives and the like may be included . Formulations for parenteral administration include sterilized aqueous solutions, non-aqueous solutions, suspensions, emulsions, freeze-dried preparations, and suppositories. Examples of the suspending agent include propylene glycol, polyethylene glycol, vegetable oil such as olive oil, injectable ester such as ethyl oleate, and the like. As a base for suppositories, witepsol, macrogol, tween 61, cacao paper, laurin, glycerogelatin and the like can be used.
본 발명에서 사용되는 용어 "투여"는 임의의 적절한 방법으로 개체에게 소정의 본 발명의 조성물을 제공하는 것을 의미한다.The term "administering" as used herein is meant to provide any desired composition of the invention to a subject in any suitable manner.
본 발명의 조성물의 바람직한 투여량은 개체의 상태 및 체중, 질병의 정도, 약물형태, 투여경로 및 기간에 따라 다르지만, 당업자에 의해 적절하게 선택될 수 있다. 바람직한 효과를 위해서, 본 발명의 조성물의 일일투여량은 1 mg/ kg 내지 10000 mg/kg의 양으로 투여할 수 있으며 하루에 한번 투여할 수도 있고, 수 회 나누어 투여할 수도 있다. The preferred dosage of the composition of the present invention varies depending on the condition and the weight of the individual, the degree of disease, the type of drug, the route of administration and the period of time, but can be appropriately selected by those skilled in the art. For a desired effect, the daily dose of the composition of the present invention may be administered in an amount of 1 mg / kg to 10000 mg / kg, and may be administered once a day or divided into several times.
본 발명의 조성물은 개체에게 다양한 경로로 투여될 수 있다. 투여의 모든 방식은 예상될 수 있는데, 예를 들면, 경구, 직장 또는 정맥, 근육, 피하, 자궁 내 경막 또는 뇌혈관 내 주사에 의해 투여될 수 있으며, 숙취 해소를 위하여 단독으로, 또는 다른 방법들과 병용하여 사용할 수 있다.The compositions of the present invention may be administered to a subject in a variety of routes. All modes of administration may be expected, for example, by oral, rectal or intravenous, intramuscular, subcutaneous, intra-dural or intracerebroventricular injection, alone for hangover resolution, or by other methods Can be used together.
또한, 본 발명은 헛개나무 추출물, 참나무 추출물 및 탈염 용암해수를 유효성분으로 함유하는 숙취 예방 또는 개선용 건강기능식품을 제공한다. Further, the present invention provides a health functional food for prevention or improvement of hangover, comprising Hovenia dulcis extract, oak extract, and desalted lava sea water as an active ingredient.
또한, 본 발명은 헛개나무 추출물, 참나무 추출물 및 탈염 용암해수를 유효성분으로 함유하는 숙취해소용 음료를 제공한다.In addition, the present invention provides a beverage for hangover containing an extract of Hovenia dulcis, an oak extract, and desalted seawater as an active ingredient.
본 발명의 헛개나무 추출물, 참나무 추출물 및 탈염 용암해수를 건강기능식품 또는 음료에 사용할 경우, 상기 헛개나무 추출물, 참나무 추출물 및 탈염 용암해수를 그대로 첨가하거나 다른 식품 또는 식품 성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효성분의 혼합양은 사용 목적(예방, 건강 또는 치료적 처치)에 따라 적합하게 결정될 수 있다. 일반적으로, 식품 또는 음료의 제조 시에 본 발명의 탈염 용암해수는 원료에 대하여 15중량 % 이하, 바람직하게는 10 중량 % 이하의 양으로 첨가된다. 그러나, 건강 및 위생을 목적으로 하거나 또는 건강 조절을 목적으로 하는 장기간의 섭취의 경우에는 상기 범위 이하일 수 있으며, 안전성 면에서 아무런 문제가 없기 때문에 유효성분은 상기 범위 이상의 양으로도 사용될 수 있다.When the hinoki extract, oak extract and desalted lava sea water of the present invention are used for a health functional food or beverage, the hinoki extract, oak extract, and desalted lava sea water can be directly added or used together with other food or food ingredients, Can be suitably used according to the method of The amount of the active ingredient to be mixed can be suitably determined according to the intended use (prevention, health or therapeutic treatment). Generally, the desalted lava waters of the present invention are added in an amount of not more than 15% by weight, preferably not more than 10% by weight based on the raw material, in the production of food or beverage. However, in the case of long-term intake for the purpose of health and hygiene or for the purpose of controlling health, the amount may be less than the above range, and since there is no problem in terms of safety, the active ingredient may be used in an amount exceeding the above range.
상기 식품의 종류에는 특별한 제한은 없다. 상기 물질을 첨가할 수 있는 식품의 예로는 육류, 소시지, 빵, 초콜릿, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 수프, 음료수, 차, 드링크제, 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 식품을 모두 포함한다.There is no particular limitation on the kind of the food. Examples of the foods to which the above substances can be added include dairy products including meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen noodles, gums, ice cream, various soups, drinks, tea, Beverages, and vitamin complexes, all of which include foods in a conventional sense.
상기 음료는 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 포함할 수 있다. 상술한 천연 탄수화물은 포도당, 과당과 같은 모노사카라이드, 말토오스, 수크로오스와 같은 디사카라이드, 및 덱스트린, 사이클로덱스트린과 같은 천연 감미제나, 사카린, 아스파르탐과 같은 합성 감미제 등을 사용할 수 있다. 상기 천연 탄수화물의 비율은 본 발명의 조성물 100 ml 당 일반적으로 약 0.01 내지 10 g, 바람직하게는 약 0.01 내지 0.1 g 이다.The beverage may contain various flavors or natural carbohydrates as an additional ingredient such as a conventional beverage. The natural carbohydrates may be monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, natural sweeteners such as dextrin and cyclodextrin, synthetic sweeteners such as saccharine and aspartame, and the like. The ratio of the natural carbohydrate is generally about 0.01 to 10 g, preferably about 0.01 to 0.1 g per 100 ml of the composition of the present invention.
상기 외에 본 발명의 조성물은 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 포함할 수 있다. 그 밖에 본 발명의 조성물은 천연 과일주스, 과일주스 음료 및 야채 음료의 제조를 위한 과육을 포함할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. 이러한 첨가제의 비율은 크게 중요하진 않지만 본 발명의 조성물 100중량부 당 0.01 내지 0.1 중량부의 범위에서 선택되는 것이 일반적이다.In addition to the above, the composition of the present invention may further contain various nutrients, vitamins, electrolytes, flavors, colorants, pectic acid and salts thereof, alginic acid and salts thereof, organic acids, protective colloid thickeners, pH adjusters, stabilizers, preservatives, glycerin, A carbonating agent used in a carbonated beverage, and the like. In addition, the composition of the present invention may comprise flesh for the production of natural fruit juices, fruit juice drinks and vegetable drinks. These components may be used independently or in combination. Although the ratio of such additives is not critical, it is generally selected in the range of 0.01 to 0.1 parts by weight per 100 parts by weight of the composition of the present invention.
이하 본 발명의 이해를 돕기 위하여 바람직한 실시예, 실험예 및 제조예를 제시한다. 그러나 하기의 실시예, 실험예 및 제조예는 본 발명을 보다 쉽게 이해하기 위하여 제공되는 것일 뿐, 이에 의해 본 발명의 내용이 한정되는 것은 아니다.Hereinafter, preferred embodiments, experimental examples, and production examples are provided to facilitate understanding of the present invention. However, the following Examples, Experimental Examples and Preparation Examples are provided only for the purpose of easier understanding of the present invention, and thus the present invention is not limited thereto.
실시예Example 1. One. 헛개나무Hinoki 추출물의 제조 Preparation of extract
헛개나무 추출물을 제조하기 위한 제조과정은 도 1에 개략적으로 나타내었다. The manufacturing process for preparing Hovenia dulcis extract is schematically shown in Fig.
도 1에 나타낸 바와 같이, 헛개나무 목재를 벌채하여 수피를 제거하는 박피작업을 수행한 후, 칩 제조기로 잘라 목재 칩을 제조하였다. 그 후 상기 목재 칩을 5~20배 부피의 물에 담지시키고 10~48시간 동안 함침 처리한 후 이를 탈수시켰으며, 탈수된 목재 칩을 70~150℃의 온도에서 30분~3시간 동안 가열하켰다. 가열된 목재 칩은 수증기와 함께 밀폐된 용기 내에 넣고 포화 상태를 유지시키며 120~300℃의 온도 및 10 ~ 40kgf/㎠의 압력에서 0.1~1시간 동안 연화하였다. 그 후 연화된 목재 칩을 대기중에 방출하여 목재 칩을 팽창시키고, 팽창된 목재 칩을 50~200℃의 열수추출기에서 5~20배 부피의 물에 넣어 0.1~3시간 동안 추출하였다. 추출 공정에서 생성된 잔사와 여액을 원심분리기를 사용하여 약리성분을 분리한 후, 여과지를 이용하여 감압 여과하여 잔사를 제거하였으며, 50℃에서 회전진공농축기(Rotavapor R-205, BUCHI, Postfach, Switzerland)를 이용하여 감압 농축하였다. As shown in Fig. 1, a hippocampus wood was clipped and peeled to remove bark, and then cut with a chip maker to produce a wood chip. Then, the wood chips were impregnated in water of 5 to 20 times volume, impregnated for 10 to 48 hours, dehydrated, and the dehydrated wood chip was heated at a temperature of 70 to 150 ° C for 30 minutes to 3 hours I turned it on. The heated wood chip was placed in a sealed container together with water vapor and maintained in a saturated state and softened at a temperature of 120 to 300 ° C and a pressure of 10 to 40 kgf / cm 2 for 0.1 to 1 hour. The softened wood chips were then released into the atmosphere to expand the wood chips and the expanded wood chips were extracted in a 5 to 20 times volume of water in a hot water extractor at 50 to 200 DEG C for 0.1 to 3 hours. The residue and the filtrate produced in the extraction process were separated using a centrifuge, and the residue was removed by filtration using a filter paper. The residue was dissolved in a rotary vacuum concentrator (Rotavapor R-205, BUCHI, Postfach, Switzerland ) Under reduced pressure.
실시예Example 2. 참나무 추출물의 제조 2. Manufacture of oak extract
참나무 추출물을 제조하기 위한 제조과정은 도 1에 개략적으로 나타내었다. The manufacturing process for producing the oak extract is schematically shown in Fig.
도 1에 나타낸 바와 같이, 참나무 목재를 벌채하여 수피를 제거하는 박피작업을 수행한 후, 칩 제조기로 잘라 목재 칩을 제조하였다. 그 후 상기 목재 칩을 5~20배 부피의 물에 담지시키고 10~48시간 동안 함침 처리한 후 이를 탈수시켰으며, 탈수된 목재 칩을 열판 체스트기로 70~150℃의 온도에서 30분~3시간 동안 가열하였다. 가열된 목재 칩은 수증기와 함께 밀폐된 용기 내에 넣고 포화 상태를 유지시키며 120~300℃의 온도 및 10 ~ 40kgf/㎠의 압력에서 0.1~1시간 동안 연화하였다. 그 후 연화된 목재 칩을 대기중에 방출하여 목재 칩을 팽창시키고, 팽창된 목재 칩을 50~200℃의 열수추출기에서 5~20배 부피의 물에 넣어 0.1~3시간 동안 추출하였다. 추출 공정에서 생성된 잔사와 여액을 원심분리기를 사용하여 약리성분을 분리한 후, 여과지를 이용하여 감압 여과하여 잔사를 제거하였으며, 50℃에서 회전진공농축기(Rotavapor R-205, BUCHI, Postfach, Switzerland)를 이용하여 감압 농축하였다. As shown in Fig. 1, the oak timber was cut to remove the bark, followed by cutting with a chip maker to produce a wood chip. Then, the wood chips were impregnated in water of 5 to 20 times volume, impregnated for 10 to 48 hours and dehydrated. The dehydrated wood chips were heat-treated at a temperature of 70 to 150 ° C for 30 minutes to 3 hours Lt; / RTI > The heated wood chip was placed in a sealed container together with water vapor and maintained in a saturated state and softened at a temperature of 120 to 300 ° C and a pressure of 10 to 40 kgf / cm 2 for 0.1 to 1 hour. The softened wood chips were then released into the atmosphere to expand the wood chips and the expanded wood chips were extracted in a 5 to 20 times volume of water in a hot water extractor at 50 to 200 DEG C for 0.1 to 3 hours. The residue and the filtrate produced in the extraction process were separated using a centrifuge, and the residue was removed by filtration using a filter paper. The residue was dissolved in a rotary vacuum concentrator (Rotavapor R-205, BUCHI, Postfach, Switzerland ) Under reduced pressure.
실시예Example 3. 제주 3. Jeju 용암해수의Lava 성분 분석 Component analysis
본 발명의 유효성분인 제주 용암해수의 성분을 확인하기 위하여, 제주도 동부지역 북제주군 구좌읍에서 용암해수를 수득한 후 유도결합플라즈마 원자방출분광광도계(ICP Spectrophotometer)를 이용하여 먹는 물의 품질을 검사할 때 기준이 되는 칼슐(Ca), 마그네슘(Mg), 나트륨(Na), 칼륨(K), 인(P), 구리(Cu), 아연(Zn), 철(Fe), 망간(Mn), 납(Pb), 카드뮴(Cd), 알루미늄(Al), 비소(As) 등 13개 원소의 함량을 조사하였다. 이때 일반 수돗물을 대조군으로 이용하였으며, 그 결과를 하기 표 1에 나타내었다.In order to confirm the constituents of Jeju lava sea water which is an effective ingredient of the present invention, lava seawater was obtained from Gujwa-eup, Bukjeju-gun, eastern Jeju Island, and then the quality of water to be inspected was measured using an inductively coupled plasma atomic emission spectrometer (ICP spectrophotometer) (Mg), sodium (Na), potassium (K), phosphorus (P), copper (Cu), zinc (Zn), iron (Fe), manganese ), Cadmium (Cd), aluminum (Al) and arsenic (As) were investigated. At this time, general tap water was used as a control group, and the results are shown in Table 1 below.
단위 : ppm(mg/L), *N.D는 0.1ppm 이하의 결과이거나 검출되지 않음Unit: ppm (mg / L), * N.D is less than or equal to 0.1 ppm
표 1에 나타낸 바와 같이, 용암해수는 수돗물에 비해 칼슘, 마그네슘, 나트륨, 칼륨과 같은 미네랄 성분의 함량이 월등히 높은 것으로 확인되었다. 수돗물 대비 제주 용암해수의 칼슘은 4.7배, 마그네슘은 214배, 나트륨은 37배, 칼륨은 10배 높은 수치를 나타내었다. 이는 수돗물의 경우 정수장을 거치면서 고도로 정제된 반면, 용암해수는 해수를 원수로 하는 특성으로 인해 미네랄 함량이 매우 높게 나타나는 것으로 추정되었다. 용암해수와 수돗물 모두에서 중금속 성분들은 검출되지 않았다.As shown in Table 1, the content of minerals such as calcium, magnesium, sodium and potassium was significantly higher in lava seawater than tap water. Calcium of Jeju lava seawater was 4.7 times, magnesium was 214 times, sodium was 37 times, and potassium was 10 times higher than tap water. It was estimated that the tap water was highly refined while passing through the water treatment plant, while the lava water was estimated to have a very high mineral content due to the characteristics of the seawater as the raw water. Heavy metal components were not detected in both lava seawater and tap water.
또한, 상기 용암해수를 본 발명에 이용하기 위하여 탈염하였으며, 이상의 과정을 통해 수득한 탈염 용암해수를 이하 실험에 이용하였다.In addition, the lava water was desalted for use in the present invention, and the desalted lava waters obtained through the above procedure were used in the following experiments.
실시예Example 4. 4. 헛개나무Hinoki 추출물의 성분 분석 Analysis of components of extract
실시예 1에서 제조된 헛개나무 추출물의 성분을 확인하기 위하여, 가스 크로마토그래프 질량분석기(gas chromatograph mass spectrometer; GC/MS)(Agilent사, 7890A-5975C GC/MSD)를 이용하였다. 이때 컬럼은 DB-5ms(30m×250m×0.25m)를 사용하였고, 컬럼의 온도는 50℃에서 300℃까지 5/min로 승온하였다. 검출기는 MSD(Mass Selective Detector)를 사용하였으며, 그 결과를 하기 표 2 및 도 2에 나타내었다.A gas chromatograph mass spectrometer (GC / MS) (Agilent, 7890A-5975C GC / MSD) was used to identify the components of the Hovenia dulcis extracts prepared in Example 1. At this time, DB-5 ms (30 m × 250 m × 0.25 m) was used as the column, and the temperature of the column was raised from 50 ° C. to 300 ° C. at a rate of 5 / min. MSD (Mass Selective Detector) was used as the detector, and the results are shown in Table 2 and FIG.
time(min)time (min)
area(%)area (%)
표 2 및 도 2에 나타낸 바와 같이, 아세트산(acetic acid)이 가장 높은 피크면적을 나타내었으며, 휘발성 향기 성분으로서 furaneol도 확인되었다.As shown in Table 2 and Fig. 2, acetic acid showed the highest peak area, and furaneol was also identified as a volatile flavor component.
실시예Example 5. 추가 식물 추출물의 성분 분석 5. Component analysis of additional plant extracts
상기 실시예 4와 동일한 방법을 이용하여 갈화, 울금, 여주 및 포공영의 성분을 분석하였다.The components of Galviniae, Ulmus, Lycaeus, and Pseudomonas aeruginosa were analyzed using the same method as in Example 4 above.
4-1. 4-1. 갈화Gall
갈화의 GC/MS 분석 결과를 하기 표 3 및 도 3에 나타내었다.The results of the GC / MS analysis of gallstone are shown in Table 3 and FIG.
time(min)time (min)
area(%)area (%)
표 3 및 도 3에 나타낸 바와 같이, 아세트산(acetic acid)을 비롯하여 Guaiacol 및 Maltol 등이 확인되었다.As shown in Table 3 and FIG. 3, acetic acid, guaiacol, maltol and the like were confirmed.
4-2. 4-2. 울금Kool
울금의 GC/MS 분석 결과를 하기 표 4 및 도 4에 나타내었다.The GC / MS analysis results of Ulugum are shown in Table 4 and FIG.
time(min)time (min)
area(%)area (%)
표 4 및 도 4에 나타낸 바와 같이, 유칼리프톨(Eucalyptol) 등이 확인되었다.As shown in Table 4 and Fig. 4, eucalyptol and the like were confirmed.
4-3. 여주4-3. Yeoju
여주의 GC/MS 분석 결과를 하기 표 5 및 도 5에 나타내었다.The GC / MS analysis results of Yeoju are shown in Table 5 and FIG.
time(min)time (min)
area(%)area (%)
4-4. 4-4. 포공영POE
포공영의 GC/MS 분석 결과를 하기 표 6에 나타내었다.The results of GC / MS analysis of POCs are shown in Table 6 below.
time(min)time (min)
area(%)area (%)
Pentacyclo[9.5.1.1(3,9).1(5,15).1(7,13)]octasiloxane, octamethyl-Octamethylsilsesquioxane;
Pentacyclo [9.5.1.1 (3,9) .1 (5,15) .1 (7,13)] octacyloxane, octamethyl-
실시예Example 5. 혼합음료의 제조 1 5. Preparation of mixed drinks 1
상기 실시예 1 및 2에서 제조된 헛개나무 추출물 및 참나무 추출물을 동결건조기에서 -85℃로 건조하여 분말상태로 제조한 후 상기 실시예 3에서 수득한 탈염 용암해수와 혼합하여 혼합음료를 제조하였다. The hinoki extracts and oak extracts prepared in Examples 1 and 2 were dried in a freeze dryer at -85 캜 to prepare powdered beverages, and mixed with the desalted lava waters obtained in Example 3 to prepare mixed beverages.
실시예Example 6. 혼합음료의 제조 2 6. Manufacturing of mixed drinks 2
상기 실시예 1 및 2에서 제조된 헛개나무 추출물 및 참나무 추출물을 동결건조기에서 -85℃로 건조하여 분말 상태로 제조하고, 예덕나무 추출물, 갈화, 어성초, 여주, 울금, 자소엽, 포공영 및 빼빼목 추출물 또한 동일한 방법으로 각각 분말 상태로 제조하였으며, 이를 상기 실시예 3에서 수득한 탈염 용암해수와 혼합하여 혼합음료를 제조하였다. The hinoki extracts and oak extracts prepared in Examples 1 and 2 were dried at -85 ° C in a freeze dryer to prepare powdery form. The extracts were prepared by extracting the extracts of Yeduckweed, Ganoderma lucidum, Yeoju, The extracts were also prepared in powder form in the same manner and mixed with the desalted lava waters obtained in Example 3 to prepare mixed beverages.
실험예Experimental Example 1. 혼합음료의 1. Mixed drinks ALDHALDH (( aldehydealdehyde dehydrogenasedehydrogenase ) 활성 측정) Active measurement
본 발명의 혼합음료의 아세트알데히드 분해 효소(aldehyde dehydrogenase, ALDH)의 활성측정을 위하여 아세트알데히드 분석키트(Megazyme Co., Ltd., Wicklow, Germany)를 사용하여 키트의 권장 절차에 따라 측정하였다. 먼저 상기 실시예 5에서 제조한 혼합음료 2.1 mL(100 mg/mL)에 소듐 아자이드(sodium azide) 완충액(pH 9.0) 0.2 mL과 NAD+ 0.2 mL을 혼합하여, 2분간 반응시킨 후 UV-분광광도계를 이용하여 340 nm에서 흡광도를 측정하였다(A1). 그 후 ALDH 효소 0.05 mL을 가하여 3~4분간 반응시킨 후 UV-분광광도계를 이용하여 340 nm에서 흡광도를 측정하였다(A2). 이때 대조군으로서 증류수를 사용하였고, ALDH의 활성은 하기와 같은 식으로 계산하였으며, 그 결과를 도 6에 나타내었다.The activity of the aldehyde dehydrogenase (ALDH) of the mixed beverage of the present invention was measured according to the recommended procedure of the kit using an acetaldehyde assay kit (Megazyme Co., Ltd., Wicklow, Germany). First, 0.2 mL of sodium azide buffer (pH 9.0) and 0.2 mL of NAD + were added to 2.1 mL (100 mg / mL) of the mixed drink prepared in Example 5, and the mixture was reacted for 2 minutes. Absorbance was measured at 340 nm using a photometer (A1). After that, 0.05 mL of ALDH enzyme was added and reacted for 3 ~ 4 minutes. Absorbance was measured at 340 nm using a UV-spectrophotometer (A2). At this time, distilled water was used as a control group, and the activity of ALDH was calculated by the following equation, and the result is shown in FIG.
도 6에 나타낸 바와 같이, 대조군의 ALDH의 활성은 100%로 나타났고, 갈화 111%, 어성초 224%, 여주 202%, 자소엽 129%, 포공영 232%, 빼빼목 114% 및 혼합음료 290%로 확인되어, 본 발명의 혼합음료의 경우 대조군과 비교할 때, 유의적으로 높은 ALDH 활성을 나타냄을 확인하였다. 특히 본 발명의 혼합음료는 갈화, 자소엽 및 빼빼목에 비하여 약 2배 이상의 활성을 나타내어 ALDH 제거 및 숙취해소에 효과적일 것으로 판단되었다.As shown in FIG. 6, the activity of ALDH in the control group was 100%. The activity of ALDH in control group was 111%, 224%, 202%, 129%, 232%, 114% and 290% As a result, it was confirmed that the mixed beverage of the present invention exhibited significantly higher ALDH activity as compared with the control group. In particular, the mixed beverage according to the present invention exhibited an activity of about twice or more as much as that of gall bladder, myofibroblast and scabbard, and thus it was considered to be effective in eliminating ALDH and hangover.
실험예Experimental Example 2. 혼합음료의 숙취해소 효과 임상 실험 2. Clinical trial of hangover effect of mixed drinks
본 발명의 혼합음료의 숙취해소 효과를 임상적으로 확인하기 위하여 시판되는 호흡용 알코올 측정기(DA-5000, Datech Co., Korea)를 사용하여 호흡 중 알코올 농도를 측정하였다. 임상실험을 위하여 경상대학교 농업생명과학대학 환경재료과학과 학생 중 평균 주량이 소주 1병 이상으로 술을 즐겨 마시고, 연구에 흥미를 가지고 참여를 원하는 대학생 16명을 조사대상자로 하였으며, Park et al(1998)이 실시한 실험 방법을 응용하였다. In order to clinically confirm the hangover resolution effect of the mixed beverage of the present invention, the alcohol concentration during respiration was measured using a commercially available respiratory alcohol meter (DA-5000, Datech Co., Korea). For the clinical experiment, 16 college students who enjoyed drinking with more than 1 bottle of soju and interested in study and participated in the study were selected as subjects for the study. Park et al (1998 The experimental method was applied.
먼저 조사대상자들의 음주 전 식품 섭취 상태를 유사하게 하기 위해서 음주시작 2시간 전에 가벼운 식사를 하도록 하고, 오후 7시에 음주를 시작하였다. 임상실험은 두 그룹으로 나누어 대조군 그룹에서는 음주 30분 전 물 200 mL를 섭취하였고, 숙취음료 섭취군 그룹에서는 상기 실시예 5에서 제조한 혼합음료를 200 mL씩 음용하게 하였다. 각각의 시료 음용 30분 후 알코올(16.5%) 360 mL를 30분 안에 일정한 속도로 나누어 마시도록 하였으며, 소량의 안주를 일정량 제공하였다. 모든 피실험자는 실험이 진행되는 동안 담배를 피우지 못하게 하였고, 물도 마실 수 없었으며, 화장실은 자유로이 출입할 수 있도록 하였다. 그 후 음주가 끝난 시점을 기점으로 하여 30분, 60분, 90분 및 120분에 호흡 중 알코올 농도를 측정하였으며, 그 결과를 도 7에 나타내었다.First, the subjects were asked to eat light meals two hours before the beginning of drinking to resemble the food intake before drinking, and they started drinking at 7 pm. The experimental group was divided into two groups. In the control group, 200 mL of water was consumed 30 minutes before drinking. In the group of hangover drink group, 200 mL of the mixed drink prepared in Example 5 was consumed. After 30 minutes of drinking each sample, 360 mL of alcohol (16.5%) was divided into portions at a constant rate within 30 minutes. All the subjects were allowed to smoke during the experiment, could not drink water, and allowed the restroom to freely enter and exit. After that, the alcohol concentration was measured at 30 minutes, 60 minutes, 90 minutes and 120 minutes from the end of drinking, and the results are shown in FIG.
도 7에 나타낸 바와 같이, 알코올 섭취 30분 경과 후 대조군에서는 0.084%, 숙취해소 혼합음료 섭취군에서는 0.059%, 60분 경과 후 대조군에서는 0.068%, 숙취해소 혼합음료 섭취군에서는 0.053%, 90분 경과 후 대조군에서는 0.084%, 숙취해소 혼합음료 섭취군에서는 0.065%, 120분 경과 후 대조군에서는 0.068%, 숙취해소 혼합음료 섭취군에서는 0.048%로 대조군에 비해 숙취해소 혼합음료 섭취군에서 낮은 알코올 농도를 나타내는 것을 확인하였다.As shown in FIG. 7, after 30 minutes of alcohol consumption, 0.084% in the control group, 0.059% in the hangover solution mixed drink group, 0.068% in the control group after 60 minutes, 0.053% in the hangover solution mixed drink group, , 0.048% in the control group, 0.065% in the hangover drink mixed drink group, 0.068% in the control group after 120 minutes, and 0.048% in the hangover drink mixed drink group, indicating lower alcohol concentration in the hangover drink mixed drink group Respectively.
또한, 숙취해소 혼합음료 섭취군의 호흡 중 알코올 농도를 흡연 유무로 구분하여 측정하였으며, 그 결과를 도 8에 나타내었다.The alcohol concentration in the respiration of the group of drinkers with hangover elimination mixed drink was divided into the presence or absence of smoking and the result was shown in FIG.
도 8에 나타낸 바와 같이, 알코올 섭취 30분 경과 후 비흡연자 숙취해소 음료 섭취군에서 0.055%, 흡연자 숙취해소 음료 섭취군에서 0.047%, 60분 경과 후 비흡연자 숙취해소 혼합음료 섭취군에서 0.050%, 흡연자 숙취해소 혼합음료 섭취군에서 0.047%, 90분 경과 후 비흡연자 숙취해소 혼합음료 섭취군에서 0.050%, 흡연자 숙취해소 혼합음료 섭취군에서 0.050%, 120분 경과 후 비흡연자 숙취해소 혼합음료 섭취군에서 0.025%, 흡연자 숙취해소 혼합음료 섭취군에서 0.043%로, 알코올 농도 변화에 있어서 비흡연자 및 흡연자에 따른 유의한 차이는 나타나지 않았다. 다만, 120분 경과 후, 흡연자 숙취해소 음료 섭취군에 비해 비흡연자 숙취해소 음료 섭취군에서 낮은 알코올 농도를 나타내어 흡연자에 비해 비흡연자에게 숙취해소 음료 섭취가 더 효과적일 것으로 판단되었다. As shown in FIG. 8, 0.055% in the non-smoker hangover elimination drink group, 0.047% in the smoker hangover elimination drink group, 0.050% in the non-smoker hangover elimination drink group after 60 minutes, Smokers hangover resolution 0.047% in mixed drink group, 0.050% in non-smoker hangover elimination group 0.050% in smoking group, 0.050% in smokers in mixed drink group, non-smoker hangover in mixed drink group , 0.025%, and 0.043% in smokers' hangover elimination mixed drink group, respectively. There was no significant difference in alcohol concentration according to nonsmokers and smokers. However, after 120 minutes, it was lower in non - smoker hangover drink drink group than non - smoker hangover drink drink group. Therefore, non - smoker was more effective than non - smoker drinking hangover drink.
또한, 숙취해소 혼합음료 섭취군의 호흡 중 알코올 농도를 성별로 구분하여 측정하였으며, 그 결과를 도 9에 나타내었다.In addition, the alcohol concentration in the respiration of the hangover-eliminating mixed drink group was measured by sex, and the results are shown in FIG.
도 9에 나타낸 바와 같이, 알코올 섭취 30분 경과 후 남성 숙취해소 음료 섭취군에서 0.073%, 여성 숙취해소 음료 섭취군에서 0.050%, 60분 경과 후 남성 숙취해소 음료 섭취군에서 0.060%, 여성 숙취해소 음료 섭취군에서 0.048%, 90분 경과 후 남성 숙취해소 음료 섭취군에서 0.090%, 여성 숙취해소 음료 섭취군에서 0.050%, 120분 경과 후 남성 숙취해소 음료 섭취군에서 0.067%, 여성 숙취해소 음료 섭취군에서 0.036%로, 남성 숙취해소 음료 섭취군은 시간경과에 따라 알코올 농도 변화에 유의한 경향이 나타나지 않았으나 여성 숙취해소 음료 섭취군은 시간경과에 따라, 알코올 농도가 안정적으로 감소하는 경향을 나타냈으며, 90분 및 120분 경과 시, 남성 숙취해소 음료 섭취군에 비해 낮은 알코올 농도를 나타내어 숙취해소 음료의 섭취는 남성에 비해 여성에게 더 효과적일 것으로 판단되었다.As shown in FIG. 9, 0.037% in male drink hangover drink drink group, 0.050% in female hangover drink drink group, 0.060% in male hangover drink drink group after 60 minutes, and 0.060% in female drink hangover drink drink group 0.048% in drink ingestion group, 0.090% in male drink hanging drink drink group, 0.050% in female hangover drink drink group, 0.067% in male hangovers drink drink group, 0.048% in female drink hanging drink drink group , And 0.036% in the group with alcoholic beverages, while alcoholic beverages showed no tendency to change the alcohol concentration with time, but alcoholic beverages had a tendency to decrease steadily over time , 90 minutes, and 120 minutes, the alcohol concentration was lower than that of the male hangover elimination drink group, and the intake of hangover drink was more effective for the female than the male It was considered.
상기 결과에 따라, 본 발명의 헛개나무 추출물, 참나무 추출물 및 탈염 용암해수는 인체 혈중 알코올 농도를 감소시키고, 숙취 증상을 완화시킴으로써 숙취 예방 또는 개선용 조성물로 유용하게 사용될 수 있음을 알 수 있었다.According to the above results, it was found that the Hovenia dulcis extract, oak extract and desalted lava sea water of the present invention can be effectively used as a composition for preventing or improving hangover by reducing blood alcohol concentration in the human body and alleviating hangover symptoms.
이하 본 발명의 약학적 조성물 및 식품 조성물의 제제예를 설명하나, 이는 본 발명을 한정하고자 함이 아닌 단지 구체적으로 설명하고자 함이다.Hereinafter, formulation examples of the pharmaceutical composition and the food composition of the present invention will be described, but the present invention is not intended to be limited thereto but is specifically described.
제제예Formulation example 1. 약학적 제제 1. Pharmaceutical preparations
1-1. 산제의 제조 1-1. Manufacture of Powder
본 발명의 조성물 20mg20 mg of the composition of the present invention
유당 100 mg
탈크 10 mgTalc 10 mg
상기의 성분들을 혼합하고 기밀포에 충진하여 산제를 제조한다.The above components are mixed and filled in airtight bags to prepare powders.
1-2. 정제의 제조1-2. Manufacture of tablets
본 발명의 조성물 10 mg10 mg of the composition of the present invention
옥수수전분 100 mg
유당 100 mg
스테아린산 마그네슘 2 mgMagnesium stearate 2 mg
상기의 성분들을 혼합한 후 통상의 정제의 제조방법에 따라서 타정하여 정제를 제조한다.After mixing the above components, tablets are prepared by tableting according to the usual preparation method of tablets.
1-3. 캡슐제의 제조1-3. Preparation of capsules
본 발명의 조성물 10 mg10 mg of the composition of the present invention
결정성 셀룰로오스 3 mgCrystalline cellulose 3 mg
락토오스 14.8 mgLactose 14.8 mg
마그네슘 스테아레이트 0.2 mgMagnesium stearate 0.2 mg
통상의 캡슐제 제조방법에 따라 상기의 성분을 혼합하고 젤라틴 캡슐에 충전하여 캡슐제를 제조한다.The above components are mixed according to a conventional capsule preparation method and filled in gelatin capsules to prepare capsules.
1-4. 주사제의 제조1-4. Injection preparation
본 발명의 조성물 10 mg10 mg of the composition of the present invention
만니톨 180 mg180 mg mannitol
주사용 멸균 증류수 2974 mgSterile sterilized water for injection 2974 mg
Na2HPO42H2O 26 mgNa 2 HPO 4 2H 2 O 26 mg
통상의 주사제의 제조방법에 따라 1 앰플당(2 ml) 상기의 성분 함량으로 제조한다.(2 ml) per 1 ampoule in accordance with the usual injection preparation method.
1-5. 액제의 제조1-5. Manufacture of liquid agent
본 발명의 조성물 20 mg20 mg of the composition of the present invention
이성화당 10 g10 g per isomer
만니톨 5 g5 g mannitol
정제수 적량Purified water quantity
통상의 액제의 제조방법에 따라 정제수에 각각의 성분을 가하여 용해시키고 레몬향을 적량 가한 다음 상기의 성분을 혼합한 다음 정제수를 가하여 전체를 정제수를 가하여 전체 100 ml로 조절한 후 갈색병에 충진하여 멸균시켜 액제를 제조한다.Each component was added and dissolved in purified water according to the usual liquid preparation method, and the lemon flavor was added in an appropriate amount. Then, the above components were mixed, and purified water was added thereto. The whole was added with purified water to adjust the total volume to 100 ml, And sterilized to prepare a liquid preparation.
제제예Formulation example 2. 식품 제제 2. Food preparation
2-1. 건강식품의 제조2-1. Manufacture of health food
본 발명의 조성물 100 mg100 mg of the composition of the present invention
비타민 혼합물 적량Vitamin mixture quantity
비타민 A 아세테이트 70 g 70 g of vitamin A acetate
비타민 E 1.0 mgVitamin E 1.0 mg
비타민 B1 0.13 mgVitamin B1 0.13 mg
비타민 B2 0.15 mg0.15 mg of vitamin B2
비타민 B6 0.5 mgVitamin B6 0.5 mg
비타민 B12 0.2 g 0.2 g of vitamin B12
비타민 C 10 mgVitamin C 10 mg
비오틴 10 g Biotin 10 g
니코틴산아미드 1.7 mgNicotinic acid amide 1.7 mg
엽산 50 g Folate 50 g
판토텐산 칼슘 0.5 mgCalcium pantothenate 0.5 mg
무기질 혼합물 적량Mineral mixture quantity
황산제1철 1.75 mg1.75 mg of ferrous sulfate
산화아연 0.82 mg0.82 mg of zinc oxide
탄산마그네슘 25.3 mgMagnesium carbonate 25.3 mg
제1인산칼륨 15 mgPotassium monophosphate 15 mg
제2인산칼슘 55 mgSecondary calcium phosphate 55 mg
구연산칼륨 90 mg
탄산칼슘 100 mg
염화마그네슘 24.8 mgMagnesium chloride 24.8 mg
상기의 비타민 및 미네랄 혼합물의 조성비는 비교적 건강식품에 적합한 성분을 바람직한 실시예로 혼합 조성하였지만, 그 배합비를 임의로 변형 실시하여도 무방하며, 통상의 건강식품 제조방법에 따라 상기의 성분을 혼합한 다음, 과립을 제조하고, 통상의 방법에 따라 건강식품 조성물 제조에 사용할 수 있다.Although the composition ratio of the above-mentioned vitamin and mineral mixture is comparatively mixed with a composition suitable for health food as a preferred embodiment, the compounding ratio may be arbitrarily modified, and the above ingredients are mixed according to a conventional method for producing healthy foods , Granules can be prepared and used in the manufacture of health food compositions according to conventional methods.
2-2. 2-2. 건강음료의Health drink 제조 Produce
본 발명의 조성물 100 mg100 mg of the composition of the present invention
비타민 C 15 gVitamin C 15 g
비타민 E(분말) 100 gVitamin E (powder) 100 g
젖산철 19.75 g19.75 g of ferrous lactate
산화아연 3.5 g3.5 g of zinc oxide
니코틴산아미드 3.5 gNicotinic acid amide 3.5 g
비타민 A 0.2 gVitamin A 0.2 g
비타민 B1 0.25 gVitamin B1 0.25 g
비타민 B2 0.3 gVitamin B2 0.3 g
물 적량Water quantity
통상의 건강음료 제조방법에 따라 상기의 성분을 혼합한 다음, 약 1시간 동안 85℃에서 교반 가열한 후, 만들어진 용액을 여과하여 멸균된 2 l 용기에 취득하여 밀봉 멸균한 뒤 냉장 보관한 다음 본 발명의 건강음료 조성물 제조에 사용한다.The above components were mixed according to a conventional health drink manufacturing method, and the mixture was stirred and heated at 85 DEG C for about 1 hour. The solution thus prepared was filtered and sterilized in a sterilized 2 liter container, It is used in the production of the health beverage composition of the invention.
상기 조성비는 비교적 기호음료에 적합한 성분을 바람직한 실시예로 혼합 조성하였지만 수요계층이나, 수요국가, 사용용도 등 지역적, 민족적 기호도에 따라서 그 배합비를 임의로 변형 실시하여도 무방하다.Although the compositional ratio is relatively mixed with a component suitable for a favorite drink, it is also possible to arbitrarily modify the compounding ratio according to the regional or national preference such as the demand class, the demanding country, and the use purpose.
Claims (14)
(a) 목재 칩을 물에 침지시킨 후 탈수시키는 공정;
(b) 상기 탈수된 목재 칩을 70~150℃에서 0.5~3시간 동안 가열하는 공정;
(c) 상기 가열된 목재 칩과 수증기를 120~300℃의 온도 및 10~40kgf/㎠의 압력에서 0.1~1시간 동안 반응시켜 연화하는 공정;
(d) 상기 연화된 목재 칩을 대기중에 방출하여 팽창시키는 공정;
(e) 상기 팽창된 목재 칩을 50~200℃에서 열수추출하는 공정; 및
(f) 상기 추출물을 분리, 정제 및 감압 농축하는 공정;을 통해 추출된 것을 특징으로 하는, 숙취 예방 또는 개선용 조성물.The method according to claim 1, wherein the oak extract
(a) dewatering the wood chips after immersing them in water;
(b) heating the dehydrated wood chips at 70 to 150 DEG C for 0.5 to 3 hours;
(c) softening the heated wood chips and water vapor by reacting them at a temperature of 120 to 300 ° C and a pressure of 10 to 40 kgf / cm 2 for 0.1 to 1 hour;
(d) releasing and expanding the softened wood chips into the atmosphere;
(e) subjecting the expanded wood chips to hot water extraction at 50 to 200 DEG C; And
(f) a step of separating, purifying and concentrating the extract under reduced pressure.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160110591A KR101896520B1 (en) | 2016-08-30 | 2016-08-30 | Hangover drink comprising desalinized magma seawater and wood extracts and process for the production thereof |
PCT/KR2017/009406 WO2018044024A1 (en) | 2016-08-30 | 2017-08-29 | Composition for relieving hangovers, containing desalinized magma seawater and wood extract, and method for preparing active ingredients thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160110591A KR101896520B1 (en) | 2016-08-30 | 2016-08-30 | Hangover drink comprising desalinized magma seawater and wood extracts and process for the production thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20180024421A true KR20180024421A (en) | 2018-03-08 |
KR101896520B1 KR101896520B1 (en) | 2018-09-07 |
Family
ID=61301037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160110591A KR101896520B1 (en) | 2016-08-30 | 2016-08-30 | Hangover drink comprising desalinized magma seawater and wood extracts and process for the production thereof |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR101896520B1 (en) |
WO (1) | WO2018044024A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102436259B1 (en) * | 2021-09-30 | 2022-08-26 | 에코클린플랫폼(주) | Hazardous substance adsorption member comprising biodegradable polymer to which natural product-derived composition is applied |
WO2022250443A1 (en) * | 2021-05-25 | 2022-12-01 | (주)산하바이오 | Composition containing medicinal plants as active ingredients for relieving hangovers |
KR20220159263A (en) * | 2021-05-25 | 2022-12-02 | (주)산하바이오 | Composition for relieving hangovers containing medicinal plants as an active ingredient |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100944042B1 (en) * | 2007-10-05 | 2010-02-24 | (주)이원희바이오매스인스티튜트 | Woody plant extract with antidiabetic activity |
KR20100080972A (en) * | 2009-01-05 | 2010-07-14 | 김선일 | Fermentation sap of tree sap and using means |
KR101114439B1 (en) * | 2008-11-06 | 2012-08-23 | 정윤석 | The food composition for lightening hangover, including extracts of Acer tegmentosum Max. and Quercus acutissima and Pine tree and Big cone tree |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20090077572A (en) * | 2008-01-11 | 2009-07-15 | 주식회사 바이오랜드 | Composition for treating or preventing metabolic syndrome-related diseases comprising desalinized magma seawater |
-
2016
- 2016-08-30 KR KR1020160110591A patent/KR101896520B1/en active IP Right Grant
-
2017
- 2017-08-29 WO PCT/KR2017/009406 patent/WO2018044024A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100944042B1 (en) * | 2007-10-05 | 2010-02-24 | (주)이원희바이오매스인스티튜트 | Woody plant extract with antidiabetic activity |
KR101114439B1 (en) * | 2008-11-06 | 2012-08-23 | 정윤석 | The food composition for lightening hangover, including extracts of Acer tegmentosum Max. and Quercus acutissima and Pine tree and Big cone tree |
KR20100080972A (en) * | 2009-01-05 | 2010-07-14 | 김선일 | Fermentation sap of tree sap and using means |
Non-Patent Citations (7)
Title |
---|
Effect of a soy-sprout beverage prepared with high-concentrated oxygen water on alcohol metabolism in rats. Korean J Food Sci Technol 46(5) : 616-621, Sung HM, Jung HJ, Yun SK, Kim TY, Kim KM and Wee JH (2014) |
Effect of dandelion juice supplementation on alcohol-Induced oxidative stress and hangover in healthy male college students. J Korean Soc Food Sci Nutr 38(6) : 683-693, Noh KH, Jang JH, Kim JJ, Shin JH, Kim DK and Song YS (2009) |
Effect of flower of pueraria lobata on lipid peroxidation and activities of alcohol metabolic enzymes in alcohol- treated rats. J Korean Soc Food Sci Nutr 29(5) : 935-942, Lee Js, Kim NY, Lee KH, Kim GS, Park HJ, Choi JW and Kim SH (2000) |
Protective effects of branched-chain amino acid (BCAA)-enriched corn gluten hydrolysates on ethanol-induced hepatic injury in rats. Korean J Food Sci Technol 41: 706-711, Chung YI, Bae IY, Lee JY, Chun HS and Lee HG (2009) |
Study of the antioxidant and alcohol-degrading enzyme activities of soybean sprout sugar solutions. Korean J Food Sci Technol. 46(5) : 581-587, Kim KM, Jung HJ, Sung HM, Wee JH, Kim TY and Kim KM (2014) |
The effect of mildronate on serum alcohol concentration and hangover syndrome. J Korean Soc Food Sci Nutr 27 : 168-174, Park SM, Kang BK and Chung TH (1998) |
인터넷 기사(‘용암해수산업화, 이정도면 도전해볼만하지 않는가?’, 제주의소리, 2011.04.20.)* * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022250443A1 (en) * | 2021-05-25 | 2022-12-01 | (주)산하바이오 | Composition containing medicinal plants as active ingredients for relieving hangovers |
KR20220159263A (en) * | 2021-05-25 | 2022-12-02 | (주)산하바이오 | Composition for relieving hangovers containing medicinal plants as an active ingredient |
KR102436259B1 (en) * | 2021-09-30 | 2022-08-26 | 에코클린플랫폼(주) | Hazardous substance adsorption member comprising biodegradable polymer to which natural product-derived composition is applied |
Also Published As
Publication number | Publication date |
---|---|
KR101896520B1 (en) | 2018-09-07 |
WO2018044024A1 (en) | 2018-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Khiraoui et al. | Nutritional and biochemical properties of natural sweeteners of six cultivars of Stevia rebaudiana Bertoni leaves grown in Morocco | |
KR101301094B1 (en) | Composition for relieving hangover or improving liver function | |
KR102001740B1 (en) | Liquid composition for preventing and relieving hangover with high content of ginsenoside F2, R3 and compound K comprising and preparation method thereof | |
KR101896520B1 (en) | Hangover drink comprising desalinized magma seawater and wood extracts and process for the production thereof | |
KR100979251B1 (en) | Jujube beverage and method for manufacturing thereof | |
KR20100119150A (en) | Composition for alleviating a hangover comprising an extract of chestnut(castanea crenata) inner skin | |
KR101978336B1 (en) | Method for manufacturing concentrate of Aronia | |
KR101845160B1 (en) | Pharmaceutical composition comprising the extraction of salicornia spp. seed as an effective component for prevention or treatment of thrombosis and health functional food comprising the same | |
KR101706017B1 (en) | Hepatoprotective composition comprising extracts of fruits of stauntonia hexaphylla for preventing alcoholic liver injury | |
JP5775922B2 (en) | Xanthine oxidase inhibitor and uric acid production inhibitor | |
KR101393598B1 (en) | Healthy food composition for healing a hangover | |
KR101327645B1 (en) | Composition for antioxidative defenses system and muscle fatigue recovery comprising Angelica keiskei extract and Eisenia bicyclis extract as active ingredients | |
KR20150088223A (en) | Compositions for preventing or improving of alcoholic liver disease, or reducing alcoholic hangup comprising Rosa rugosa extracts | |
KR100684435B1 (en) | Composition comprising the extract of dioscorea quinqueloba and viscum album var. coloratum showing anti-oxidative, anti-aging by anti-lipidperoxidative, anti-inflammatory and discharge of phlegm activity | |
KR102147592B1 (en) | Composition for rerpessing smoking and health functional food containing the composition | |
JP3819413B1 (en) | Food containing food ingredients with bitter or astringent taste | |
KR101968891B1 (en) | Composition for treating hangover comprising extracts of fruits of stauntonia hexaphylla | |
KR101636608B1 (en) | Composition for antioxidation comprising the seed extract of cornus officinalis | |
KR101482044B1 (en) | Food composition comprising fermented product of Pleuropterus multiflorus and ginger for alleviating or preventing degenerative brain disorder and method of producing the same | |
KR102489041B1 (en) | Production method of low salt napa cabbage kimchi using functional spice | |
KR102628352B1 (en) | Food Composition for Relieving Hangover Comprising Extracts of Dendropanax Morbifera and Hovenia Dulcis | |
KR102575784B1 (en) | Method for manufacturing liquor using Citrus Junos peel and Citrus Junos liquor produced by the method | |
KR20090087183A (en) | Beverage composition | |
KR20120016688A (en) | Composition for curing a hangover | |
CN112167612A (en) | Method for extracting aromatic ester substances from Elaeagnus angustifolia fruits |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant |